Indian stocks: Visit www.stage2stocks.com →

Amarin Corporation plc

Stage 4 · Declining · week 12

As of Oct 22, 2026, Amarin is in Stage 4, the downtrend phase, now in week 12 (since Aug 3, 2026). It closed at $11.60, 41.2% below its 52-week high and below its 200-day average, which is falling.

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. More about the company

$11.60
+0.87% today
$245M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is AMRN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 20w
S4 40w
S2 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 20w → S1 6w → S2 6w → S3 5w → S4 40w → S1 7w → S4 9w → S1 3w → S2 14w → S3 2w → S2 10w → S3 7w → S4 5w → S1 4w → S4 11w → S1 5w → S4 12w current
Total tracked: 166 weeks across 17 stage runs.

AMRN among Drug Manufacturers - General17th of 21 by relative strength

All 21 →
Stocks in Drug Manufacturers - General ranked by relative strength, with stage and one-month change
#StockStageRS1M
1MRKStage 2 · wk 1692−0.6%
2BIIBStage 2 · wk 2192+11.6%
3LLYStage 2 · wk 190+13.5%
4AMGNStage 2 · wk 1687+10.1%
5OGNStage 2 · wk 2387+0.1%
6BMYStage 3 · wk 185+4.1%
7JNJStage 2 · wk 1683−0.6%
8PFEStage 2 · wk 877+7.9%
…17AMRNStage 4 · wk 1227−15.5%
vs 52W High
-41.2%
$11.32 lo$19.72 hi
41.2% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 12
1w13w26w
Week 12, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-19.5%
200 DMA: $14.41 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.39x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-15.5%
3M
-14.4%
6M
-20.5%
YTD
-15.5%
1Y
-41.8%
Scan Membership
Breakout Watch
Latest: 2025-06-17
8 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 12 · Vol 0.39x
2026-10-21S4
Wk 12 · Vol 0.50x
2026-10-20S4
Wk 12 · Vol 0.41x
2026-10-19S4
Wk 11 · Vol 1.12x
2026-10-16S4
Wk 11 · Vol 1.67x
2026-10-15S4
Wk 11 · Vol 0.80x
2026-10-14S4
Wk 11 · Vol 0.75x
2026-10-13S4
Wk 11 · Vol 1.51x
2026-10-12S4
Wk 10 · Vol 1.34x
2026-10-09S4
Wk 10 · Vol 0.67x
2026-10-08S4
Wk 10 · Vol 0.92x
2026-10-07S4
Wk 10 · Vol 1.12x
Moving averages & range
50 DMA
$13.20
200 DMA
$14.41
52W High
$19.72
52W Low
$11.32
5D Low
$11.32
Resistance levels (recent highs)
20d High
$13.25
60d High
$14.41
120d High
$16.47
250d High
$19.72
Next resistance
+14.2%
to 20d High
ROE
-6.0%
Profit margin -14.6%
Dividend Yield
0.00%
P/B 0.5

Amarin: quick answers

What stage is Amarin in?

As of Oct 22, 2026, Amarin (AMRN) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 3, 2026 and is in week 12. What the four stages mean

Is Amarin in an uptrend?

No. Amarin is in a Stage 4 downtrend. It trades 19.5% below its 200-day average, which is falling.

How far is Amarin from its 52-week high?

Amarin closed at $11.60 on Oct 22, 2026, 41.2% below its 52-week high of $19.72. Its 52-week low is $11.32.

How has Amarin performed over the past year?

As of Oct 22, 2026, Amarin is down 41.8% over the past year and down 15.5% so far in 2026.

Which sector and industry is Amarin in?

Amarin is in the Drug Manufacturers - General industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - General

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.